Sertraline HCl Market
- 2026 年市場規模
- USD 2.1 Bn
- 2033 年預估規模
- USD 3.1 Bn
- 年複合成長率 CAGR
- 4.1%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Sertraline HCl Market, By Type (25 mg, 50 mg, 100 mg and Others), By Application (Obsessive-Compulsive Disorder, Depression, Panic Disorder, Premenstrual Dysphoric Disorder, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa)
報告摘要
Sertraline HCl belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Sertraline HCl has the same mechanism of action as other SSRIs. It works by increasing the amount of serotonin that is available in the brain. Serotonin is a neurotransmitter, or chemical messenger, that is involved in regulating many elements of a person’s daily life, including mood, sleep, rewards, learning, and memory. Research has linked depression with low levels of serotonin. Sertraline increases the amount of serotonin present in the brain, helping to reduce chemical imbalances and improve a person’s overall mood. Sertraline is available as either an oral tablet or a liquid. Typically, a person takes a dose in the morning or evening, once a day. People using it to treat premenstrual dysphoric disorder may take it every day or only on select days of the month.
Market Dynamics
Key trends in the market include increasing prescription rate and expenditure for antidepressant drug which is expected to drive the market growth during the forecast period. For instance, according to an article published in Springer Nature Switzerland AG in March 2021, stated that the total number of Ads (antidepressants) prescriptions dispensed during COVID-19 pandemic (January to December 2020) were 78 million, 4 million more than in 2019 that costed the National Health Service (NHS) is the publicly funded healthcare system in England, £139 million (US $170.7 million) more than in 2019. Sertraline, an SSRI antidepressant drug, alone accounted for an extra £113 million (US $ 138.7 million) during 2020 than in 2019.
Key features of the study
• This report provides an in-depth analysis of the global sertraline HCl market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global sertraline HCl market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
• Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Accord Biopharma, Apotex Inc., Aurobindo Pharma USA, InvaGen, Lupin, Camber Pharmaceuticals, Mylan (a part of Viatris Inc.), Sun Pharmaceutical, Wockhardt, Alpic Biotech
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global sertraline HCl market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sertraline HCl market.
Market Segmentation
• By Type
o 25 mg
o 50 mg
o 100 mg
o Others
• By Application
o Obsessive-Compulsive Disorder
o Depression
o Panic Disorder
o Premenstrual Dysphoric Disorder
o Others
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Pfizer Inc.
o Teva Pharmaceutical Industries Ltd.
o Novartis AG
o Accord Biopharma
o Apotex Inc.
o Aurobindo Pharma USA
o InvaGen
o Lupin
o Camber Pharmaceuticals
o Mylan N.V. (a Part of Viatris Inc.)
o Sun Pharmaceutical
o Wockhardt
o Alpic Biotech
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Type
Market Snapshot, By Application
Market Snapshot, By Distribution channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Opportunity
o Impact Analysis
o Regulatory Scenario
o Market Trends
o Key Developments
o Epidemiology
o PEST Analysis
o Collaboration and Acquisition
o Porters Analysis
o Pipeline Analysis
4. Global Sertraline HCL Market, By Type, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o 25 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o 50 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o 100 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Sertraline HCL Market, By Application, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Obsessive-Compulsive Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Depression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Panic Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Premenstrual Dysphoric Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Sertraline HCL Market, By Distribution channel, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Sertraline HCL Market, By Region, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2030
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Pfizer
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Teva Pharmaceutical Industries Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Novartis AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Accord Biopharma
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Apotex Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Aurobindo Pharma USA
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
InvaGen
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Lupin
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Camber Pharmaceuticals
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Mylan N.V. (a part of Viatris Inc.)
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Sun Pharmaceutical
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Wockhardt
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Alpic Biotech
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
9. Section
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們